PA
MRNS

Perceptive Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Perceptive Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-226,933
Closed -$9.08M – 129
2018
Q3 		$9.08M Hold
226,933
– – 0.24% 59
2018
Q2 		$6.42M Hold
226,933
– – 0.17% 67
2018
Q1 		$3.47M Hold
226,933
– – 0.1% 85
2017
Q4 		$7.41M Sell
226,933
-136,242
-38% -$3.67M 0.25% 63
2017
Q3 		$8.53M Buy
+363,175
New +$4.07M 0.33% 55

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
JG
Jefferies Group New York $3.42B AUM 6.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return